vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and TRUPANION, INC. (TRUP). Click either name above to swap in a different company.
TRUPANION, INC. is the larger business by last-quarter revenue ($376.9M vs $207.8M, roughly 1.8× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $25.3M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
TRUPANION, INC.TRUPEarnings & Financial Report
Trupanion, Inc. is a pet insurance provider headquartered in Seattle, Washington. Established in 1998, Trupanion operates across the United States, Canada, Australia, and Puerto Rico. The company offers coverage for pets and is self-underwritten by the American Pet Insurance Company (APIC).
IDYA vs TRUP — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $376.9M |
| Net Profit | $119.2M | — |
| Gross Margin | — | 17.3% |
| Operating Margin | 52.2% | 1.9% |
| Net Margin | 57.4% | — |
| Revenue YoY | — | 11.7% |
| Net Profit YoY | 330.1% | — |
| EPS (diluted) | $1.33 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $376.9M | ||
| Q3 25 | $207.8M | $366.9M | ||
| Q2 25 | — | $353.6M | ||
| Q1 25 | — | $342.0M | ||
| Q4 24 | — | $337.3M | ||
| Q3 24 | $0 | $327.5M | ||
| Q2 24 | $0 | $314.8M | ||
| Q1 24 | $0 | $306.1M |
| Q4 25 | — | — | ||
| Q3 25 | $119.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.8M | — | ||
| Q2 24 | $-52.8M | — | ||
| Q1 24 | $-39.6M | — |
| Q4 25 | — | 17.3% | ||
| Q3 25 | — | 16.4% | ||
| Q2 25 | — | 15.5% | ||
| Q1 25 | — | 14.9% | ||
| Q4 24 | — | 15.7% | ||
| Q3 24 | — | 15.1% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 11.8% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | 52.2% | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | -0.4% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | -1.7% | ||
| Q1 24 | — | -2.0% |
| Q4 25 | — | — | ||
| Q3 25 | 57.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $0.13 | ||
| Q3 25 | $1.33 | $0.13 | ||
| Q2 25 | — | $0.22 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | — | $0.04 | ||
| Q3 24 | $-0.60 | $0.03 | ||
| Q2 24 | $-0.68 | $-0.14 | ||
| Q1 24 | $-0.53 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $370.7M |
| Total DebtLower is stronger | — | $101.8M |
| Stockholders' EquityBook value | $1.1B | $383.9M |
| Total Assets | $1.2B | $915.0M |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $370.7M | ||
| Q3 25 | $786.9M | $348.5M | ||
| Q2 25 | — | $319.6M | ||
| Q1 25 | — | $321.8M | ||
| Q4 24 | — | $307.4M | ||
| Q3 24 | $920.0M | $293.1M | ||
| Q2 24 | $701.7M | $277.2M | ||
| Q1 24 | $698.8M | $275.2M |
| Q4 25 | — | $101.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $127.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $383.9M | ||
| Q3 25 | $1.1B | $368.6M | ||
| Q2 25 | — | $355.5M | ||
| Q1 25 | — | $333.7M | ||
| Q4 24 | — | $323.3M | ||
| Q3 24 | $1.2B | $320.2M | ||
| Q2 24 | $931.7M | $305.8M | ||
| Q1 24 | $935.3M | $303.4M |
| Q4 25 | — | $915.0M | ||
| Q3 25 | $1.2B | $880.2M | ||
| Q2 25 | — | $847.8M | ||
| Q1 25 | — | $837.2M | ||
| Q4 24 | — | $806.9M | ||
| Q3 24 | $1.2B | $816.1M | ||
| Q2 24 | $973.7M | $795.9M | ||
| Q1 24 | $961.5M | $789.5M |
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $29.3M |
| Free Cash FlowOCF − Capex | $142.2M | $25.3M |
| FCF MarginFCF / Revenue | 68.4% | 6.7% |
| Capex IntensityCapex / Revenue | 0.0% | 1.0% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $75.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $29.3M | ||
| Q3 25 | $142.2M | $29.2M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | — | $23.7M | ||
| Q3 24 | $-49.2M | $15.3M | ||
| Q2 24 | $-32.9M | $6.9M | ||
| Q1 24 | $-43.8M | $2.4M |
| Q4 25 | — | $25.3M | ||
| Q3 25 | $142.2M | $23.9M | ||
| Q2 25 | — | $12.0M | ||
| Q1 25 | — | $14.0M | ||
| Q4 24 | — | $21.8M | ||
| Q3 24 | $-49.7M | $13.4M | ||
| Q2 24 | $-33.9M | $4.0M | ||
| Q1 24 | $-45.1M | $-631.0K |
| Q4 25 | — | 6.7% | ||
| Q3 25 | 68.4% | 6.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 4.1% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -0.2% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
TRUP
| Subscriptionbusiness | $261.4M | 69% |
| Other | $115.4M | 31% |
